Kura Oncology

+$0.96 (+7.65%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Kura Oncology and other ETFs, options, and stocks.

About KURA

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias.

CEO
Troy E. Wilson
Employees
121
Headquarters
San Diego, California
Founded
2014

KURA Key Statistics

Market cap
900.25M
Price-Earnings ratio
—
Dividend yield
—
Average volume
572.48K
High today
$13.51
Low today
$12.41
Open price
$12.55
Volume
419.78K
52 Week high
$23.71
52 Week low
$10.41

KURA Earnings

-$0.54
-$0.36
-$0.18
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure